Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
AbbVie
ABBV
|
+$122M |
| 3 |
Zoom
ZM
|
+$109M |
| 4 |
Amazon
AMZN
|
+$105M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$103M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
Newmont
NEM
|
+$52.9M |
| 4 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 5 |
Yum! Brands
YUM
|
+$34.4M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.4% |
| 5 | Industrials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
1701
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.04M | ﹤0.01% |
138,900
+37,500
| +37% | +$552K |
|
1702
Arcus Biosciences
RCUS
$1.23B
| $2.04M | ﹤0.01% |
82,496
+37,996
| +85% | +$940K |
|
1703
Theravance Biopharma
TBPH
$720M
| $2.04M | ﹤0.01% |
97,242
+14,700
| +18% | +$309K |
|
|
CATM
1704
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $2.03M | ﹤0.01% |
84,700
+10,800
| +15% | +$259K |
|
1705
Axcelis
ACLS
$2.69B
| $2.03M | ﹤0.01% |
72,800
+9,900
| +16% | +$276K |
|
1706
Mr. Cooper
COOP
$14.1B
| $2.02M | ﹤0.01% |
162,700
+21,400
| +15% | +$266K |
|
1707
StoneX
SNEX
$5.04B
| $2.02M | ﹤0.01% |
82,800
+11,700
| +16% | +$286K |
|
1708
Core Laboratories
CLB
$581M
| $2.02M | ﹤0.01% |
99,200
+13,200
| +15% | +$268K |
|
1709
Provident Financial Services
PFS
$2.59B
| $2.02M | ﹤0.01% |
139,500
+18,300
| +15% | +$264K |
|
1710
AZZ Inc
AZZ
$3.52B
| $2.01M | ﹤0.01% |
58,600
+7,900
| +16% | +$271K |
|
1711
Ultra Clean Holdings
UCTT
$1.14B
| $2.01M | ﹤0.01% |
88,800
+11,600
| +15% | +$263K |
|
1712
Parsons
PSN
$8.18B
| $2.01M | ﹤0.01% |
55,400
+7,300
| +15% | +$265K |
|
|
LTHM
1713
DELISTED
Livent Corporation
LTHM
| $2.01M | ﹤0.01% |
325,835
+42,700
| +15% | +$263K |
|
1714
OneSpan
OSPN
$588M
| $2.01M | ﹤0.01% |
71,800
+9,400
| +15% | +$262K |
|
1715
Virtus Investment Partners
VRTS
$1.34B
| $2M | ﹤0.01% |
17,200
+3,900
| +29% | +$453K |
|
1716
Granite Construction
GVA
$4.7B
| $2M | ﹤0.01% |
104,400
+13,700
| +15% | +$262K |
|
1717
Southside Bancshares
SBSI
$916M
| $1.99M | ﹤0.01% |
71,718
+9,500
| +15% | +$263K |
|
|
SA
1718
Seabridge Gold
SA
$1.92B
| $1.99M | ﹤0.01% |
113,900
+27,800
| +32% | +$485K |
|
1719
Scholastic
SCHL
$691M
| $1.98M | ﹤0.01% |
66,200
+8,500
| +15% | +$254K |
|
|
VRN
1720
DELISTED
Veren
VRN
| $1.97M | ﹤0.01% |
1,226,600
+165,500
| +16% | +$266K |
|
1721
S&T Bancorp
STBA
$1.5B
| $1.97M | ﹤0.01% |
83,900
+11,100
| +15% | +$260K |
|
|
FOE
1722
DELISTED
Ferro Corporation
FOE
| $1.97M | ﹤0.01% |
164,600
+13,600
| +9% | +$162K |
|
|
GCP
1723
DELISTED
GCP Applied Technologies Inc.
GCP
| $1.96M | ﹤0.01% |
105,700
-21,200
| -17% | -$394K |
|
1724
Weis Markets
WMK
$1.75B
| $1.96M | ﹤0.01% |
39,000
+7,700
| +25% | +$386K |
|
1725
Tompkins Financial
TMP
$1B
| $1.95M | ﹤0.01% |
30,100
+4,000
| +15% | +$259K |
|